documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
55 rows where docket_id = "FDA-1975-N-0012" and posted_year = 2020 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1975-N-0012-0835 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | The American CIeaning Institute Progress Report | Other | Report | 2020-12-04T05:00:00Z | 2020 | 12 | 2020-12-04T05:00:00Z | 2020-12-04T16:11:45Z | 0 | 0 | 0900006484986dd3 | ||
| FDA-1975-N-0012-0834 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | FDA Updated Response to ACI July 2020 Progress Report (ethanol bzk pmcx bzec pi) | Other | Letter(s) | 2020-11-23T05:00:00Z | 2020 | 11 | 2020-11-23T05:00:00Z | 2020-11-23T13:04:07Z | 0 | 0 | 0900006484970492 | ||
| FDA-1975-N-0012-0833 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | FDA Response to ACI July 2020 Progress Report (ethanol bzk pmcx bzec pi) | Other | Agency Response | 2020-11-20T05:00:00Z | 2020 | 11 | 2020-11-20T05:00:00Z | 2020-11-20T14:36:43Z | 0 | 0 | 090000648496ca5e | ||
| FDA-1975-N-0012-0832 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | ACI Advice November 18 2020 | Other | Letter(s) | 2020-11-20T05:00:00Z | 2020 | 11 | 2020-11-20T05:00:00Z | 2020-11-20T14:31:06Z | 0 | 0 | 090000648496c57e | ||
| FDA-1975-N-0012-0831 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | ACI BZT Monograph Meeting Minutes Written Responses | Supporting & Related Material | Meeting Materials | 2020-10-06T04:00:00Z | 2020 | 10 | 2020-10-06T14:24:05Z | 0 | 0 | 09000064848be3df | |||
| FDA-1975-N-0012-0830 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Meeting Minutes for Lonza & Henkel’s benzalkonium chloride consumer antiseptic handwash July 30 2020 | Other | Minutes | 2020-08-26T04:00:00Z | 2020 | 8 | 2020-08-26T04:00:00Z | 2020-08-26T13:57:23Z | 0 | 0 | 09000064848202db | ||
| FDA-1975-N-0012-0812 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. APPROVED BY INTEGREVIEW IRB OCTOBER 25, 2019 THIS IS AN IMPORTANT DOCUMENT - KEEP FOR FUTURE REFERENCE VERSION CONTROL jr/9-27-19 rss/10-25-19 INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYre Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T18:59:45Z | 0 | 0 | 0900006484717944 | |||
| FDA-1975-N-0012-0829 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Table 14.1.1: Summary of Subject Enrollment and Disposition re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T20:15:29Z | 0 | 0 | 0900006484718b64 | |||
| FDA-1975-N-0012-0827 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Henkel Corporation, Inc. Lonza Inc. A Pilot Maximal Use Study to Measure the Systemic Absorption of Benzalkonium Chloride (BAC) after Exaggerated Use of the Antimicrobial Soap on Intact Skin with Healthy Volunteers re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T20:15:09Z | 0 | 0 | 0900006484718b62 | |||
| FDA-1975-N-0012-0816 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Listing 16.2.2 Protocol Deviations Safety Population (N=42) re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T19:39:45Z | 0 | 0 | 0900006484718732 | |||
| FDA-1975-N-0012-0819 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Listing 16.2.6.1: Hand Wash and Packaging Weights Details Safety Population (N=42) re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T19:40:29Z | 0 | 0 | 0900006484718935 | |||
| FDA-1975-N-0012-0826 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Listing 16.2.12: Comments Safety Population (N=42) re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T20:04:17Z | 0 | 0 | 0900006484718a12 | |||
| FDA-1975-N-0012-0817 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Listing 16.2.4.1: Demographics and Baseline Characteristics Safety Population (N=42) re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T19:39:55Z | 0 | 0 | 0900006484718733 | |||
| FDA-1975-N-0012-0828 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Figure 14.2.2.1: Individual Subject Plasma Levels, Linear for C12 and C14 homologs, PK Population Subject Number: 0001 at Day 1 re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T20:15:19Z | 0 | 0 | 0900006484718b63 | |||
| FDA-1975-N-0012-0823 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Listing 16.2.9: Physical Examination Results - Abnormal Findings Safety Population (N=42) re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T19:59:00Z | 0 | 0 | 090000648471893e | |||
| FDA-1975-N-0012-0821 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Data Listing 16.2.7.1: Adverse Events Safety Population (N=42) re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T19:58:43Z | 0 | 0 | 090000648471893c | |||
| FDA-1975-N-0012-0815 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Listing 16.2.1 Subject Disposition and Population Inclusion All Enrolled Subjects (N=42) re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T19:39:36Z | 0 | 0 | 0900006484718731 | |||
| FDA-1975-N-0012-0810 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. A Pilot Maximal Use Study to Measure the Systemic Absorption of Benzalkonium Chloride (BAC) After Exaggerated Use of the Antimicrobial Soap on Intact Skin in Healthy Volunteers re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T18:59:17Z | 0 | 0 | 0900006484717942 | |||
| FDA-1975-N-0012-0813 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Curriculum Vitaes re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T18:59:58Z | 0 | 0 | 0900006484717945 | |||
| FDA-1975-N-0012-0809 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Study No_TKL MC000520 CSP Final A Pivotal Maximal Use Study to Measure the Systemic Absorption of Benzalkonium Chloride (BAC) after Exaggerated Use of the Antimicrobial Soap on Intact Skin in Healthy Volunteers | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T18:59:02Z | 0 | 0 | 090000648471742e | |||
| FDA-1975-N-0012-0811 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Case Report Form Booklet Final Version # 1.0 November 04, 2019 re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T18:59:35Z | 0 | 0 | 0900006484717943 | |||
| FDA-1975-N-0012-0820 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Statistical Analysis Plan re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T19:58:33Z | 0 | 0 | 090000648471849a | |||
| FDA-1975-N-0012-0822 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Listing 16.2.8: Vital Signs Test Results Safety Population (N=42) re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T19:58:52Z | 0 | 0 | 090000648471893d | |||
| FDA-1975-N-0012-0824 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Listing 16.2.10.1: Laboratory Test Results, Chemistry, Part 1 Safety Population (N=42) re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T19:59:09Z | 0 | 0 | 0900006484718a0f | |||
| FDA-1975-N-0012-0814 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Signatures of Authors, Principal Investigator, and Sponsor's Medical Officer re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T19:17:24Z | 0 | 0 | 09000064847183f5 | |||
| FDA-1975-N-0012-0818 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Listing 16.2.5.1: Plasma Concentration (ng/L) - C12 homologs Safety Population (N=42) re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use SORRY | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T19:40:18Z | 0 | 0 | 0900006484718734 | |||
| FDA-1975-N-0012-0825 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Inc. Listing 16.2.11: Childbearing Potential and Urine Pregnancy Test Results All Female Subjects (N= 20) re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2020-06-29T04:00:00Z | 2020 | 6 | 2020-06-29T20:01:41Z | 0 | 0 | 0900006484718a11 | |||
| FDA-1975-N-0012-0788 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-5-2-coas-of-reference-standards | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:03:08Z | 0 | 0 | 090000648470d126 | ||
| FDA-1975-N-0012-0787 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-5-1-preparation-acceptance-criteria-for-cc-qc-sop | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:01:40Z | 0 | 0 | 090000648470d125 | ||
| FDA-1975-N-0012-0797 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-6-3-ba-3rd-add-to-validationreport | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:17:07Z | 0 | 0 | 090000648470d515 | ||
| FDA-1975-N-0012-0785 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix 2_BAC IVDP Foaming Liquid Handwashes 06.2020 CRL FINAL Report | Supporting & Related Material | Background Material | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T17:09:01Z | 0 | 0 | 090000648470c91d | |||
| FDA-1975-N-0012-0807 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-5-2-coas-of-reference-standards | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:41:14Z | 0 | 0 | 090000648470d834 | ||
| FDA-1975-N-0012-0800 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-6-2-ba-2nd-add-to-validationreport | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:40:02Z | 0 | 0 | 090000648470d80c | ||
| FDA-1975-N-0012-0799 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-6-ba-validationreport | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:39:52Z | 0 | 0 | 090000648470d5e5 | ||
| FDA-1975-N-0012-0796 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-6-2-ba-2nd-add-to-validationreport | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:15:53Z | 0 | 0 | 090000648470d0ff | ||
| FDA-1975-N-0012-0808 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-5-1-preparation-acceptance-criteria-for-cc-qc-sop | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:41:23Z | 0 | 0 | 090000648470d836 | ||
| FDA-1975-N-0012-0802 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-5-bioanalyt-pmut-052019 | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:40:28Z | 0 | 0 | 090000648470d810 | ||
| FDA-1975-N-0012-0803 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-5-6-incurred-samples-reanalysis-sop | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:40:37Z | 0 | 0 | 090000648470d812 | ||
| FDA-1975-N-0012-0790 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-5-4-representative-chromatograms | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:07:11Z | 0 | 0 | 090000648470d128 | ||
| FDA-1975-N-0012-0805 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-5-4-result-tables-of-all-runs | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:40:57Z | 0 | 0 | 090000648470d830 | ||
| FDA-1975-N-0012-0786 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix 3_lonza_pmut_052019_csr | Supporting & Related Material | Background Material | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T17:10:56Z | 0 | 0 | 090000648470c964 | |||
| FDA-1975-N-0012-0784 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix 1_Lonza FINAL July 3_2019 Prelim Meeting Preliminary Commt for July 2019 MTG | Supporting & Related Material | Background Material | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T17:09:14Z | 0 | 0 | 090000648470c91c | |||
| FDA-1975-N-0012-0793 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-5-7-incurred-samples-reanalysis-sop | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:11:20Z | 0 | 0 | 090000648470d174 | ||
| FDA-1975-N-0012-0791 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-5-5-result-tables-of-all-runs | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:08:19Z | 0 | 0 | 090000648470d129 | ||
| FDA-1975-N-0012-0782 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Briefing Document BAC June 2020_Final | Other | Memo | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T17:00:38Z | 0 | 0 | 090000648470c914 | ||
| FDA-1975-N-0012-0806 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-5-3-representative-chromatograms | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:41:06Z | 0 | 0 | 090000648470d832 | ||
| FDA-1975-N-0012-0789 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-5-3-multianalyte-reanalysis-batches-data | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:04:41Z | 0 | 0 | 090000648470d127 | ||
| FDA-1975-N-0012-0804 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-5-5-Criteria-for-sample-reanalysis-and-reporting-sop | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:40:46Z | 0 | 0 | 090000648470d814 | ||
| FDA-1975-N-0012-0783 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Lonza Study No_TKL MC000520 CSP Final v1.0 19June2020 - signed | Other | Studies | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T17:01:52Z | 0 | 0 | 090000648470c915 | ||
| FDA-1975-N-0012-0792 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-5-6-Criteria-for-sample-reanalysis-and-reporting-sop | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:10:02Z | 0 | 0 | 090000648470d0db | ||
| FDA-1975-N-0012-0801 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-6-1-ba-1st-add-to-validationreport | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:40:18Z | 0 | 0 | 090000648470d80e | ||
| FDA-1975-N-0012-0794 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-5-bioanalyt-pmut-052019 | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:12:35Z | 0 | 0 | 090000648470d175 | ||
| FDA-1975-N-0012-0798 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-6-ba-validationreport | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:18:17Z | 0 | 0 | 090000648470d516 | ||
| FDA-1975-N-0012-0795 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | 16-6-1-ba-1st-add-to-validationreport | Other | Report | 2020-06-25T04:00:00Z | 2020 | 6 | 2020-06-25T04:00:00Z | 2020-06-25T19:14:43Z | 0 | 0 | 090000648470d0fe | ||
| FDA-1975-N-0012-0781 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | MONOGRAPH Meeting Granted Letter Lonza and Henkel 2020 Benzalkonium Hand Soaps | Other | Request | 2020-06-24T04:00:00Z | 2020 | 6 | 2020-06-24T04:00:00Z | 2020-06-24T13:01:00Z | 0 | 0 | 0900006484704aa9 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);